Avricore Health Inc

Avricore Health Inc. stocks swing 65% in 52 weeks; despite negative earnings, the TSX‑Venture listed pharma firm’s high P/B hints at hidden long‑term potential.

Avricore Health Inc. – TSX Venture-listed pharma firm boosting access to affordable generic and OTC meds, trading near $0.055 with a $5.57M cap.

Avricore Health Inc. has expanded its HealthTab platform into North Central London, increasing access to cholesterol screening services and empowering pharmacists to play a key role in chronic disease prevention.

Avricore Health Inc. is navigating market challenges in the pharmaceutical industry with a strategic focus on expanding its product portfolio and enhancing distribution networks.